Why InterMune Inc. Shares Exploded Higher By More Than 170%
InterMune shares soared after the company released positive late-stage trial data. Should investors jump on this runaway train or stay as far away from the tracks as possible?
Today's Biggest Biotech Stories: BioCryst, Verastem, and InterMune
BioCryst, Verastem, and InterMune could all loom large in health care headlines this morning. Here's why.